Guided Therapeutics, Inc.

OTCPK:GTHP Stock Report

Market Cap: US$6.7m

Guided Therapeutics Past Earnings Performance

Past criteria checks 0/6

Guided Therapeutics's earnings have been declining at an average annual rate of -14.8%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 4.4% per year.

Key information

-14.8%

Earnings growth rate

59.4%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate4.4%
Return on equityn/a
Net Margin-3,940.2%
Last Earnings Update31 Mar 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Guided Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:GTHP Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 240-330
31 Dec 230-430
30 Sep 230-540
30 Jun 230-540
31 Mar 230-540
31 Dec 220-530
30 Sep 220-430
30 Jun 220-320
31 Mar 220-320
31 Dec 210-220
30 Sep 210020
30 Jun 210220
31 Mar 210-420
31 Dec 200010
30 Sep 200-110
30 Jun 200-310
31 Mar 200110
31 Dec 190-210
30 Sep 190-610
30 Jun 190-610
31 Mar 190010
31 Dec 180110
30 Sep 180-410
30 Jun 180-520
31 Mar 180-1020
31 Dec 170-1130
30 Sep 170-630
30 Jun 170-420
31 Mar 170-531
31 Dec 161-531
30 Sep 161-54-1
30 Jun 161-840
31 Mar 161-950
31 Dec 151-1050
30 Sep 151-1051
30 Jun 151-1151
31 Mar 151-1060
31 Dec 141-1060
30 Sep 141-1150
30 Jun 141-950
31 Mar 141-1050
31 Dec 131-1040
30 Sep 132-750

Quality Earnings: GTHP is currently unprofitable.

Growing Profit Margin: GTHP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GTHP is unprofitable, and losses have increased over the past 5 years at a rate of 14.8% per year.

Accelerating Growth: Unable to compare GTHP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GTHP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).


Return on Equity

High ROE: GTHP's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.